Lynkcell 
Welcome,         Profile    Billing    Logout  
  Products    Diseases    Products    Trials    News 
  • ||||||||||  LYN-00101 / Lynkcell
    Enrollment change, Trial completion date, Trial withdrawal, Trial primary completion date:  Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101 (clinicaltrials.gov) -  Mar 11, 2020   
    P1,  N=0, Withdrawn, 
    N=19 --> 0 | Trial completion date: Feb 2020 --> Aug 2020 | Active, not recruiting --> Withdrawn | Trial primary completion date: Nov 2019 --> Jun 2020
  • ||||||||||  LYN-00101 / Lynkcell
    Enrollment closed, Enrollment change:  Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101 (clinicaltrials.gov) -  Apr 29, 2019   
    P1,  N=19, Active, not recruiting, 
    N=19 --> 0 | Trial completion date: Feb 2020 --> Aug 2020 | Active, not recruiting --> Withdrawn | Trial primary completion date: Nov 2019 --> Jun 2020 Recruiting --> Active, not recruiting | N=37 --> 19
  • ||||||||||  LYN-00101 / Lynkcell
    Enrollment open, Trial completion date, Trial initiation date, Trial primary completion date:  Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101 (clinicaltrials.gov) -  Apr 4, 2019   
    P1,  N=37, Recruiting, 
    Recruiting --> Active, not recruiting | N=37 --> 19 Not yet recruiting --> Recruiting | Trial completion date: Jul 2019 --> Feb 2020 | Initiation date: Oct 2018 --> Apr 2019 | Trial primary completion date: Apr 2019 --> Nov 2019